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VolumetryIn Alzheimer3s disease (AD), the hippocampus is an early site of tau pathology and neurodegeneration. Histolog-
ical studies have shown that lesions are not uniformly distributedwithin the hippocampus.Moreover, alterations
of different hippocampal layersmay reﬂect distinct pathological processes. 7 TMRI dramatically improves the vi-
sualization of hippocampal subregions and layers. In this study, we aimed to assess whether 7 T MRI can detect
volumetric changes in hippocampal layers in vivo in patients with AD. We studied four AD patients and seven
control subjects. MR images were acquired using a whole-body 7 T scanner with an eight channel transmit–
receive coil. Hippocampal subregions were manually segmented from coronal T2*-weighted gradient echo
images with 0.3 × 0.3 × 1.2 mm3 resolution using a protocol that distinguishes between layers richer or poorer
in neuronal bodies. Five subregions were segmented in the region of the hippocampal body: alveus, strata
radiatum, lacunosum and moleculare (SRLM) of the cornu Ammonis (CA), hilum, stratum pyramidale of CA
and stratum pyramidale of the subiculum. We found strong bilateral reductions in the SRLM of the cornu
Ammonis and in the stratum pyramidale of the subiculum (p b 0.05), with average cross-sectional area reductions
ranging from−29% to−49%. These results show that it is possible to detect volume loss in distinct hippocampal
layers using segmentation of 7 T MRI. 7 T MRI-based segmentation is a promising tool for AD research.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).RI, magnetic resonance imag-
A, cornu Ammonis; DG, dentate
ord Institute, Pitié-Salpêtrière,
13, France.
. This is an open access article under1. Introduction
The hippocampal formation is an early site of Alzheimer3s disease
(AD) pathology (Braak and Braak, 1991). Hippocampal atrophy is a
well-established imaging marker of Alzheimer3s disease and has been
included in recently proposed research diagnostic criteria (Albert
et al., 2011; Dubois et al., 2007; Jack et al., 2011). Hippocampal atrophy
can bemeasured fromT1-weightedmagnetic resonance imaging (MRI),
usingmanual or automated segmentation (Colliot et al., 2008; Jack et al.,
1992; Lehéricy et al., 1994) which provides an estimate of thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Demographic and clinical characteristics of the population.
Subject no. Group Gender Age MMSE CDR
1 CN F 68 30 0
2 CN F 55 30 0
3 CN F 72 29 0
4 CN F 62 27 0
5 CN M 61 29 0
6 CN M 61 30 0
7 CN M 63 29 0
8 AD M 60 25 1
9 AD M 76 21 2
10 AD M 63 17 1
11 AD M 64 13 2
CN= Cognitively normal subjects, AD= Alzheimer3s disease patients. F = Female, M =
male. Age is in years.
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tients from elderly controls with high sensitivity and speciﬁcity as dem-
onstrated by numerous studies (Jack et al., 1992; Jack et al., 1997;
Killiany et al., 1993; Laakso et al., 1996; Xu et al., 2000). Traditionally,
hippocampal volumetry considers the hippocampus as a single anatomi-
cal entity and thus only provides a global volumetric measure. However,
the hippocampal formation is an anatomically complex structure which
is composed of different subregions (Duvernoy, 2005). It is made of two
convoluted sheets of gray matter that are folded one onto another: the
cornu Ammonis (CA) and the dentate gyrus (DG). The cornu Ammonis
is further composed of four sectors: CA1–4. CA1 is the largest sector and
is continuous to the subiculum. Furthermore, subregions are composed
of different layers that vary in terms of cellular composition. The stratum
pyramidale (SP) is richer in neuronal bodies while the strata radiatum,
lacunosum and moleculare (SRLM) are poorer in neuronal bodies.
In Alzheimer3s disease, histological studies have shown that lesions
are not uniformly distributed within hippocampal subregions. Neuroﬁ-
brillary tangles, neuronal loss and decrease in synaptic density are dom-
inant in the ﬁrst sector of the cornu Ammonis (CA1) and the subiculum,
the dentate gyrus being relatively spared (Fukutani et al., 1995; Hyman
et al., 1984; Rössler et al., 2002; Scheff et al., 2007; Simić et al., 1997;
West et al., 1994). Neuronal loss results in a reduction of the thickness
of the layers richer in neuronal bodies, while the loss of synapses results
in the reduction of the layers poorer in neuronal bodies (Braak and
Braak, 1997; Lace et al., 2009; Thal et al., 2000). Histological studies
have suggested that synaptic loss in SRLM could occur earlier than neu-
ronal loss in SP (Braak and Braak, 1997; Fukutani et al., 1995; Hyman
et al., 1984; Rössler et al., 2002; Thal et al., 2000). In vivomeasurement
of hippocampal layers would thus be of major interest for AD research.
In the past years, several studies have analyzed volumes of hippo-
campal subregions in patients with AD and mild cognitive impairment
(MCI), based on advances of high-ﬁeld MRI (La Joie et al., 2013;
Mueller et al., 2010; Pluta et al., 2012). Most studies were based on
T2-weighted or proton-density weighted sequences with about
0.4mm in plane coronal resolution and 2mmslice thickness, performed
at 3 T or 4.7 T. They have reported volume reductions in different subre-
gions, including the subiculum (La Joie et al., 2013;Mueller et al., 2010),
CA1 (La Joie et al., 2013; Mueller et al., 2010; Pluta et al., 2012) and the
dentate gyrus (Pluta et al., 2012).
7 T MRI provides new contrasts, increased signal-to-noise ratio and
higher spatial resolution which dramatically improve the visualization
of hippocampal subregions (Theysohn et al., 2009). Using 7 T MRI,
Kerchner et al. (2010) found atrophy of the strata radiatum, lacunosum
and moleculare (the layers poorer in neuronal bodies) in AD patients.
However, they used linear measurements of thickness at selected points
and did not perform subregional segmentation. Wisse et al. (2012) have
proposed a new manual segmentation protocol for hippocampal subre-
gions at 7 T and subsequently applied this protocol to AD patients
(Wisse et al., 2014). However, the protocol did not distinguish between
layers richer and poorer in neuronal bodies. Chupin et al. (2009) and
Henry et al. (2011) have performed segmentation of subregions at 7 T,
using a protocol distinguishing between layers poorer and richer in neu-
ronal bodies, in healthy subjects andpatientswith temporal lobe epilepsy.
The purpose of our study was to assess if 7 T MRI-based segmenta-
tion can detect volume loss of hippocampal layers in patients with AD
compared to control subjects.
2. Materials and methods
2.1. Participants
The regional ethics committee approved this prospective study and
written informed consent was obtained from all participants. We stud-
ied four AD patients (3men, 1 woman; mean age ± standard deviation
[SD]: 65.8 ± 7.0 years, range: 60–76 years, Mini Mental State Examina-
tion [MMSE] score: 19.0 ± 5.1, range: 13–25) and seven cognitivelynormal (CN) participants (3 men and 4 women; age: 63.1 ± 5.6 years,
range: 55–72 years; MMSE score: 29.1 ± 1.1, range: 27–30). The two
groups did not differ for age (Mann–Whitney U test, p= 0.5) and gen-
der (Chi-square test, χ2 = 0.25, 1df, p = 0.62). AD patients were re-
quired to meet the criteria of the National Institute of Neurological
Disorders and Stroke andAlzheimer3s Disease and Related Disorders As-
sociation for mild to moderate AD (McKhann et al., 1984) with a CDR
(Clinical Dementia Rating Scale) of 1.0 or more and an IADL score (In-
strumental Activities of Daily Living) of more than 1 for each item or
more than 2 for one item. The criteria for the inclusion of cognitively
normal subjects were: the absence ofmemory complaint, normal scores
for MMSE, normal scores for tests of executive functions and normal
memory performance deﬁned as a free recall score of 25/48 or more
and a total recall score ofmore than44/48 in the Free and Cued Selective
Reminding Test (FCSRT). Subjects with recent cardiovascular disease
(less than 1 year), neurological or psychiatric disease (except for AD)
or focal lesion on brain MRI were excluded. Demographic and clinical
characteristics of the participants are given in Table 1.
2.2. MRI acquisition
Imaging was performed on a whole-body 7 T scanner (Magnetom
7 T, Siemens Healthcare, Erlangen, Germany) with an eight channel
transmit–receive coil. The acquisition protocol included a 3D T1-
weighted magnetization prepared rapid gradient echo (MP-RAGE) ac-
quisition covering the whole brain and a T2*-weighted 2D gradient
echo (GRE) coronal acquisition covering the hippocampal formation.
The T2*-weighted 2D gradient echo was composed of three acquisition
slabs (Fig. 1). It was angulated perpendicular to the longitudinal axis of
the hippocampus, as visualized on a parasagittal view of the 3D T1 se-
quence. Acquisition parameters of each sequence are presented in
Table 2. Prior to the study, we performed several pilot acquisitions
with different resolution and sequence parameters, with a speciﬁc
study of the inﬂuence of GRE echo time (from about 10–45ms) on con-
trast and visibility of the different layers and on the presence of artifacts
in the structure of interest. We chose the two echo times that maxi-
mized contrast while keeping a reasonable acquisition time.
2.3. Segmentation of hippocampal subregions
Manual segmentation of subregions within the hippocampal body
was performed by a trained rater (CB), blinded to clinical data and diag-
nosis. The rater (C.B.) is a neuroradiologist with 3 years of experience in
neuroradiology at the time when the segmentations were carried out.
She had previous experience of hippocampal segmentation and was
speciﬁcally trained to the neuroanatomy of hippocampal subregions
and their segmentation on MRI data. Segmentation was performed on
the longer echo T2*-weighted images of the second acquisition slab
and external borders of hippocampal subregions were reﬁned on the
ﬁrst echo. Each slice was visually inspected and the visibility of the
Fig. 1. Illustration of the positioning of the three acquisition slabs of the T2*-weighted GRE
sequence, based on a T1-weighted parasagittal view. The last posterior slice of the ﬁrst
acquisition slab was positioned on the last slice of the head of the hippocampus. The
ﬁrst acquisition slab is represented in orange, the second in green and the third in blue.
343C. Boutet et al. / NeuroImage: Clinical 5 (2014) 341–348internal structure was judged sufﬁcient to allow manual segmentation,
not masked by the movement and artifacts nor by the loss of signal.
Fig. 2 presents, in a single representative AD subject, the complete set
of slices of the second slab used to deﬁne hippocampal layers. Segmen-
tation was done using the object-based ROI module of the Anatomist
software (http://www.brainvisa.info/index.html). The hippocampal head
and tail were not segmented because the more complex shape of
these structures posed difﬁculties in labeling procedures that were dif-
ﬁcult to solve with the GRE images, susceptibility artifacts yielding
more blurred borders in the head of the hippocampus.
Manual segmentation of hippocampal body subregions was per-
formed using the following protocol, extending the one proposed by
Henry et al. (2011). The hippocampal body was subdivided in ﬁve sub-
regions based on the anatomy described by Duvernoy (2005). The fol-
lowing subregions were sequentially segmented. (1) Alveus. (2) SRLM
corresponding to the strata radiatum, lacunosum and moleculare of
CA1–3, the strata lacunosum and moleculare of the subiculum and the
stratum moleculare of the dentate gyrus (DG). This corresponds to the
layers poorer in neuronal bodies. (3) Hilum corresponding to the
stratum pyramidale of CA4 and the stratum granulosum and poly-
morphic layer of DG, which are the layers richer in neuronal bodies.
(4) Cornu Ammonis Stratum Pyramidale (CA_SP), assumed to corre-
spond to the stratum pyramidale of CA1–3, layers richer in neuronal
bodies of CA1–3. (5) Subiculum_SP corresponding to the stratum
pyramidale of the subiculum, layers richer in neuronal bodies of
the subiculum. The ﬁmbria was not considered here, due to the dif-
ﬁculties in discriminating it from blood vessels on T2* weighted
images.
Anterior and posterior limits of the segmented region in the hippo-
campal body were deﬁned on coronal sections, with reference mainly
to sagittal sections to ensure 3D consistency. The ﬁrst slice considered
for the segmentation was chosen as the ﬁrst slice posterior to theTable 2
MRI acquisition protocol.
Sequence Acquisition plane and coverage Number of slices Field of view Matrix
MP-RAGE Sagittal - Head 176 230 × 230 256 ×
2D T2* GRE Coronal - Hippocampal formation 3 × 15 173 × 100 576 ×
MP-RAGE =Magnetization prepared rapid gradient echo; GRE = gradient recalled echo; TR/Tuncus. The posterior slice of the segmentation was the last slice of the
middle slab. The ﬁve subregions were then segmented as follows.
1. Alveus. The superior medial border of the alveus was set at the point
where CA merges within the hilum; its inferior lateral border was at
the junction with the collateral eminence of the lateral ventricle.
2. SRLM. The superior medial border of SRLM was straightforward to
deﬁne as the point where CA revolved around it to enter the hilum;
its inferior medial border corresponded to the point where the
parahippocampal gyrus bulged upwards and changed slope.
3. Hilum. The superior medial border of the hilum was the ﬁmbrio-
dentate sulcus; its superior border was deﬁned by drawing an imag-
inary line between the superior medial borders of the alveus and
SRLM, and could be described as the end of the ribbon-like aspect
of CA; its inferior lateral border was formed by SRLM; its medial bor-
der was deﬁned by the cerebro-spinal ﬂuid in the cisterna ambiens.
4. CA_SP. CA_SPwas delineated between the alveus and SRLM. Its supe-
rior border was determined by the hilum; its inferior medial border
was deﬁned as follows: ﬁrst by tracing the largest diameter of the
hilum, then by tracing a line perpendicular to the CA axis passing
by the medium of the hilum diameter. This perpendicular line was
the infero-medial border of CA_SP.
5. Subiculum_SP. The medial limit corresponded to that of SRLM; the
superior border was SRLM; its inferior border was the temporal
white matter.
2.4. Comparison to linear measurement of hippocampal subregions
For comparisonwith volumetric measures, we also performedman-
ual linear measurements of thickness, as in Kerchner et al. (2010) for
SRLM, CA_SP and Subiculum_SP.While Kerchner et al. (2010)measured
SRLM and CA_SP, we chose to also measure thickness of Subiculum_SP
for comparison with our volumetric measurements of this speciﬁc
structure. Linear measurements were made by the same rater (CB),
blind to manual segmentation, using Dicom Viewer 2.0 software
(Rubo Medical Imaging, the Netherlands) on the longer echo T2*-
weighted images of the second acquisition slab. Linear measures were
performed using the following procedure that was chosen as close as
possible to that of Kerchner et al. (2010). Thickness was measured by
drawing an orthogonal line between two tissue plane interfaces. Six lin-
ear measurements were made for each side and for each subregion, on
two different slices at the level of red nucleus (three measurements on
each slice for each subregion). We chose two slices separated from each
other by 2.4 mm and not adjacent slices since the slice thickness
(1.2 mm) of our acquisitions was different from that of Kerchner et al.
(2010) (2 mm). This allows to have a distance between the two slices
which is as close as possible to that of Kerchner et al. (2010). For each
subregion and each side, we computed the average of the 6 linear
measurements.
2.5. Statistical analysis
We normalized the volume of each subregion to the ipsilateral body
length, resulting in measures of average cross-sectional area. Group
differences in subregional areas between AD and CN subjects were
assessed using Mann–Whitney U tests. Group differences in linear
thickness measures were also assessed using Mann–Whitney U tests.Acquisition time Flip angle TR/TE/TI (ms) Resolution (mm)
256 11 min 6° 2640/3.28/1100 0.9 × 0.9 × 0.9
576 3 × 7 min 65° 742/16.41 (TE1); 33.22 (TE2) 0.3 × 0.3 × 1.2
E/TI = repetition time/echo time/inversion time.
Fig. 2. Coronal slices of a TE2 T2*-weighted acquisition in a single AD patient: complete set of slices of the second slab used to deﬁne hippocampal layers, in an anterior-to-posterior
direction from a to i.
344 C. Boutet et al. / NeuroImage: Clinical 5 (2014) 341–348Correlation between average cross-sectional area and linear measure-
ments was assessed using Spearman3s rank correlation coefﬁcient.
Signiﬁcance threshold was set at p b 0.05. Statistical analyses were per-
formed by C.B. using MedCalc for Windows, version 12.2.1 (MedCalc
Software, Mariakerke, Belgium).
3. Results
Segmentation of hippocampal subregions was feasible in all partici-
pants. Examples of T2*-weighted acquisitions and segmented hippo-
campal subregions are presented on Figs. 3 and 4.
3.1. Volumetric measurement of hippocampal subregions
Average subregional cross-sectional areas are presented in Table 3.
Individualmeasures are presented on Fig. 5.We found strong and signif-
icant (p b 0.05) bilateral reductions of SRLM and Subiculum_SP in AD
patients compared to CN subjects. For left Subiculum_SP, there was no
overlap between patients and controls. The alveus areawas signiﬁcantly
smaller on the left in AD patients. There was a trend towards reduction
of left CA_SP area (p= 0.058).
3.2. Comparison to linear measurement of hippocampal subregions
In CN subjects, left and right average linear measurements were
respectively mean ± standard deviation = 0.69 ± 0.08 mm and
0.64 ± 0.09 mm for SRLM, 1.61 ± 0.39 mm and 1.69 ± 0.19 mm
for CA_SP and 1.76 ± 0.5 mm and 1.74 ± 0.23 for Subiculum_SP.
In AD subjects, left and right average linear measurements were re-
spectively 0.45 ± 0.04 mm and 0.49 ± 0.08 mm for SRLM, 1.17 ±0.12 mm and 1.29 ± 0.29 mm for CA_SP and 1.09 ± 0.16 mm and
1.18 ± 0.27 for Subiculum_SP. Bilaterally, SRLM and Subiculum_SP
were signiﬁcantly thinner in AD patients compared to CN subjects
(p b 0.05). Left CA_SP was also signiﬁcantly thinner (p b 0.05). Average
cross-sectional areas of SRLM, CA_SP and Subiculum_SP correlated signif-
icantly (p b 0.05) with linear measurements except for the right SRLM
(p= 0.0710).
4. Discussion
In this study, we demonstrated the feasibility ofmeasuring volumet-
ric alterations of the hippocampal inner structure in AD patients using
ultra-high resolution MRI at 7 T. In particular, we were able to dis-
tinguish in vivo layers which are richer in neuronal bodies (stratum
pyramidale — SP) from those which are poorer (strata radiatum,
lacunosum and moleculare — SRLM).
We found strong signiﬁcant bilateral atrophy of the SP of the
subiculum and of SRLM. The largest reduction was found in the left
subiculum, reaching an average of 49%. Subiculum atrophy has been
previously reported in subregional segmentation studies at 4.7 T
(Mueller et al., 2010) and 3 T (La Joie et al., 2013; Wisse et al., 2014).
Very recently, a 7 T MRI study reported subiculum and CA atrophy in
AD patients (Wisse et al., 2014). Consistently, histological studies report
large numbers of neuroﬁbrillary tangles and important neuronal loss in
the subicular area (Hyman et al., 1984; Rössler et al., 2002; Simić et al.,
1997).
We found a strong bilateral atrophy of SRLM. Dominant atrophy of
SRLM is consistent with histological knowledge which described a pri-
mary degeneration of synapse-rich CA1 SRLMwhich precedes neuronal
Fig. 3. Coronal slices of a T2×−weighted acquisition (ﬁrst echo TE1 and second echo TE2) in a CN subject and an AD patient at the level of the hippocampal body and corresponding
segmentations. Segmentations were performed on the second echo image. Purple, alveus; dark blue, CA_SP; yellow, SRLM; cyan, hilum and green, subiculum_SP. Abbreviations:
CA_SP = stratum pyramidale of CA1–3; SRLM = strata radiatum, lacunosum and moleculare of CA1–3, strata lacunosum and moleculare of the subiculum and stratum moleculare
of gyrus dentatus; hilum = stratum pyramidale of CA4 and stratum granulosum and polymorphic layer of gyrus dentatus; subiculum_SP = stratum pyramidale of the subiculum.
CN= cognitively normal, AD = Alzheimer3s disease.
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et al., 1984; Rössler et al., 2002; Thal et al., 2000). Synaptic loss in
CA1 SRLM would be due to aggregates of microtubule-associated
hyperphosphorylated tau-protein, and would appear earlier than pyra-
midal neuron loss, due to neuroﬁbrillary tangles formation, localized in
CA1 SP (Braak and Braak, 1997; Fukutani et al., 1995; Hyman et al.,
1984; Rössler et al., 2002; Thal et al., 2000). To our knowledge, only
Kerchner et al. (Kerchner et al., 2014; Kerchner et al., 2013; Kerchner
et al., 2010) have previously measured SRLM in vivo in AD patients,
initially on T2*-weighted gradient echo acquisitions with line
drawings (Kerchner et al., 2010), then on T2 Fast Spin Echo using a
semi-automated edge-detection algorithm to integrate SRLMwidth (Kerchner et al., 2014; Kerchner et al., 2013; Kerchner et al.,
2012). They also found a signiﬁcant atrophy of SRLM (Kerchner
et al., 2010). Furthermore, SRLM atrophy was stronger in APOE ε4
carriers (Kerchner et al., 2014) and shared vulnerability with the en-
torhinal cortex (Kerchner et al., 2013). The in-plane resolution in
our study is less high (0.3 mm) than that of Kerchner et al. (2010)
(0.195 mm) and our AD patients are at a later disease stage (mean
MMSE: 19 vs 23). However, our slice thickness is smaller (1.2 mm)
than that of Kerchner et al. (2010) (2 mm) resulting in less partial
volume effect and allowing a better delineation of the limits during
the segmentation. To further assess the agreement between our re-
sults and those of Kerchner et al. (2010), we compared our
Fig. 4. Three-dimensional renderings of the segmentations. Purple, alveus; dark blue, CA_SP; yellow, SRLM; cyan, hilum and green, subiculum_SP. Abbreviations: CA_SP = stratum
pyramidale of CA1–3; SRLM = strata radiatum, lacunosum and moleculare of CA1–3, strata lacunosum and moleculare of the subiculum and stratum moleculare of gyrus dentatus;
hilum= stratum pyramidale of CA4 and stratum granulosum and polymorphic layer of gyrus dentatus; subiculum_SP= stratum pyramidale of the subiculum. CN= cognitively normal,
AD= Alzheimer3s disease.
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that volumetric and linear measures were in strong agreement.
We did not ﬁnd a signiﬁcant atrophy of the stratum pyramidale of
CA, even though there was a trend towards reduction on the left. This
result is also in line with Kerchner et al. (2010) which did not ﬁnd atro-
phy of CA SP. On the other hand, several studies at lower ﬁeld strength
(3 T/4.7 T) have found atrophy of CA1 and/or CA1–2 transition in AD pa-
tients (La Joie et al., 2013;Mueller et al., 2010; Pluta et al., 2012). Several
factors may explain this difference with our results: smaller number of
patients in our study, the fact that studies at 3 T/4.7 T did not distinguish
between SP and SRLM and the fact that we did not separate CA1 from
other CA sectors. Separation of CA1 from other sectors is often based
on geometrical criteria (e.g.Mueller et al., 2007; La Joie et al., 2010).
We did not use this strategy, in order to minimize the number of arbi-
trary geometrical limits. Another option is to deﬁne the limit of CA1
based on the thinning of the stratum pyramidale, as in Kerchner et al.
(2012). Indeed, according to Duvernoy (2005), the limit between CA1
and CA2 corresponds to a thinning of the stratum pyramidale and a
thickening of the stratum moleculare. We assessed the possibility of
identifying this limit (thinning of SP) in our data but this identiﬁcation
did not prove to be reliable, in particular in AD patients. For these rea-
sons, we decided not to subsegment CA.
In the past years, substantial progresses have been made for in vivo
measurement of hippocampal subregions in AD. The ﬁrst studies of sub-
regional hippocampal atrophy in AD have relied on local shape analysis
of the external hippocampal boundary, based on various techniquesTable 3
Mean average cross-sectional area of hippocampal body subregions (volume normalized
to the ipsilateral hippocampal body length) (data are means ± standard deviations,
in mm2).
AD (n = 4) CN (n = 7)
Right Left Right Left
CA_SP 17.8 ± 4.6 (−6%) 15.2 ± 2.4** (−15%) 18.9 ± 4.1 17.9 ± 2.4
SRLM 5.6 ± 0.5* (−39%) 5.7 ± 1.2* (−29%) 9.2 ± 2.2 7.9 ± 1.3
Hilum 16.2 ± 6.0 (−4%) 12.9 ± 1.4 (−14%) 15.5 ± 3.7 14.9 ± 2.0
Subiculum_SP 8.1 ± 1.4* (−31%) 6.9 ± 0.4* (−49%) 11.8 ± 2.3 13.6 ± 2.1
Alveus 3.4 ± 0.04 (−13%) 2.8 ± 0.4* (−21%) 3.8 ± 0.5 3.6 ± 0.6
CA_SP = stratum pyramidale of CA1–3; SRLM = strata radiatum, lacunosum and
moleculare of CA1–3, strata lacunosum and moleculare of the subiculum and stratum
moleculare of gyrus dentatus; Hilum = stratum pyramidale of CA4 and stratum
granulosum and polymorphic layer of gyrus dentatus; Subiculum_SP = stratum
pyramidale of the subiculum.
* Indicates a signiﬁcant difference between AD and CN (Mann–Whitney U test,
p b 0.05).
** Indicates a trend which did not reach the signiﬁcance threshold (Mann–Whitney
U test, p = 0.058).including deformation-based (Csernansky et al., 2000; Wang et al.,
2006), radial mapping (Frisoni et al., 2008; Thompson et al., 2004),
voxel-based (Chételat et al., 2008) and spherical harmonics (Gerardin
et al., 2009) approaches. However, these approaches do not segment
hippocampal subregions and the localization of the detected local atro-
phy with respect to different subﬁelds relies on approximate mapping
to a template. More recently, using advances of high-ﬁeld MRI, several
studies have shown that it is possible to detect atrophy of hippocampal
subregions in AD and MCI patients based on T2-weighted or proton-
density-weighted sequences at 3 T or 4.7 T (La Joie et al., 2013;
Mueller et al., 2010; Pluta et al., 2012). 7 T MRI pushes even further
the ability to measure subtle anatomical alterations of hippocampal
subregions (Chupin et al., 2009; Henry et al., 2011; Kerchner et al.,
2014; Kerchner et al., 2010; Thomas et al., 2008; Wisse et al., 2014;
Wisse et al., 2012). In particular, it allows distinguishing between layers
depending on their richness in neuronal bodies. In this work, we show
that 7 T MRI reveals atrophy patterns in different subregions in AD
patients.
Our study has the following limitations. First, only few patients
were included, resulting in limited statistical power. It is thus pos-
sible that volume reductions in other subregions such as the hilum,
alveus or CA_SP would have been signiﬁcant with a larger patient
group. A related limitation is that we did not correct for multiple
comparisons corresponding to the different segmented regions.
However, one can note that most other studies (Wisse et al.,
2014; Kerchner et al., 2010; Pluta et al., 2012; Mueller et al.,
2010; La Joie et al., 2013) of hippocampal subﬁeld volumetry did
not correct for multiple comparisons either. Furthermore, a larger
patient group is required to establish the sensitivity and speciﬁcity
of these new measurements at the individual level. Another limita-
tion is that we did not assess reproducibility of volumetric mea-
sures because the manual segmentation procedure is highly time
consuming. These limitations underline the preliminary nature of
our ﬁndings.
In conclusion, we were able to detect atrophy in distinct hippocam-
pal layers in AD patients. 7 T MRI-based segmentation of hippocampal
layers is a promising new technique for AD research and future investi-
gations in that direction are worthwhile.Disclosure statement
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